✦ LIBER ✦

Health-Related Quality of Life of Patients with Primary Immunodeficiency Switching from Intravenous IgG to a New 20% Subcutaneous IgG

✍ Scribed by Teresa Gonzalez Quevedo; Wilma Mannhardt-Laakmann; Ewa Bernatowska; Margit Serban; Stephen Jolles; Javier de Gracia; Bodo Grimbacher; Ed Wang; Michael Borte

Book ID: 113541667
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 135
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2010.03.261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-Related Quality Of Life Of Japane

✍ Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, T 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 42 KB

The Construction of a Pharmacokinetic Mo

The Construction of a Pharmacokinetic Model to Describe Intravenous and Subcutaneous Supplementation of IgG in Patients with Primary Immunodeficiency (PID)

✍ Bexon, M.; Rojavin, M.; Jolles, S.; Ellis, S.; Sawyer, J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Health-Related Quality of Life and Treat

✍ Uwe Nicolay; Peter Kiessling; Melvin Berger; Sudhir Gupta; Leman Yel; Chaim M. R 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 238 KB

Efficacy and Safety of IgPro20, a 20% Im

Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy

✍ Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Patients with primary immunodeficiency r

Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety

✍ Christopher A. Jones; Mikhail Rojavin; Jeffrey S. Baggish 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Poster #S145 HEALTH-RELATED QUALITY OF L

Poster #S145 HEALTH-RELATED QUALITY OF LIFE OUTCOMES AMONG PATIENTS WITH SCHIZOPHRENIA: RESULTS FROM A LONG-TERM NATURALISTIC TRIAL OF PATIENTS SWITCHING TO LURASIDONE FROM OTHER ANTIPSYCHOTICS

✍ Rajagopalan, Krithika; Hassan, Mariam; Rajagopalan, Krithika; Awad, A. George; H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 88 KB